Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2019 Q1- Text added to 2019 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
add, ancestry, Antonio, AstraZeneca, avoid, chemotherapy, delivering, disredarded, distant, endocrine, estrogen, fertilization, ForeSight, free, high, Hispanic, immaterial, largest, maintenance, newly, offspring, ovarian, polygenic, pregnancy, receptor, San, score, spent, Symposium, timeframe
Valuein 2019 Q1 filing- Value in 2019 Q2 filing
Original filings
Filing view